Follow

Submissions from 2021

Link

Immune adverse events (irAEs) with adjuvant ipilimumab in melanoma, use of immunosuppressants and association with outcome: ECOG-ACRIN E1609 study analysis, Gary I. Cohen

Submissions from 2020

Link

The Effects of a Remote-based Weight Loss Program on Adipocytokines, Metabolic Markers, and Telomere Length in Breast Cancer Survivors: the POWER-Remote Trial, Madhu Chaudry and Gary I. Cohen

Link

Phase III Study of Adjuvant Ipilimumab (3 or 10 mg/kg) Versus High-Dose Interferon Alfa-2b for Resected High-Risk Melanoma: North American Intergroup E1609, Gary I. Cohen

Submissions from 2019

Link

Phase III Randomized Trial of Chemotherapy With or Without Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer, Athanassios Argiris, Shuli Li, Panayiotis Savvides, James P. Ohr, Jill Gilbert, Marshall A. Levine, Arnab Chakravarti, Missak Haigentz Jr, Nabil F. Saba, Chukwuemeka V. Ikpeazu, Charles J. Schneider, Harlan A. Pinto, Arlene A. Forastiere, and Barbara Burtness

Link

Safe Handling of Hazardous Drugs: ASCO Standards, Paul Celano, Christopher A. Fausel, Erin B. Kennedy, Tim M. Miller, Thomas K. Oliver, Ray Page, Jeffery C. Ward, and Robin T. Zon

Link

ASCO Standards for Safe Handling of Hazardous Drugs, Paul Celano, Erin B. Kennedy, Thomas K. Oliver, and Robin T. Zon

Link

Safe Handling of Hazardous Drugs: ASCO Standards Summary, Paul Celano, Erin B. Kennedy, and Robin T. Zon

Link

Association of Oral Human Papillomavirus DNA Persistence With Cancer Progression After Primary Treatment for Oral Cavity and Oropharyngeal Squamous Cell Carcinoma, Carole Fakhry, Amanda L. Blackford, Geoff Neuner, Weihong Xiao, Bo Jiang, Amit Agrawal, and Maura L. Gillison

Link

The American Joint Committee on Cancer turns 60, Frederick L. Greene, David R. Byrd, Robert K. Brookland, Mahul B. Amin, and Donna M. Gress

Link

Increasing PET Use in Small Cell Lung Cancer: Survival Improvement and Stage Migration in the VA Central Cancer Registry, Julian C. Hong, Matthew J. Boyer, Daphna Y. Spiegel, Christina D. Williams, Betty C. Tong, Scott L. Shofer, Michael J. Moravan, Michael J. Kelley, and Josephh K. Salama

Link

The Feasibility of Integrating Resting-State fMRI Networks into Radiotherapy Treatment Planning, Chandler Sours Rhodes, Hao Zhang, Kruti Patel, Nilesh Mistry, Young Kwok, Warren D. D'Souza, William F. Regine, and Rao P. Gullapalli

Submissions from 2018

Link

Proportion and Clinical Relevance of Intraspinal Air in Patients With Pneumomediastinum, Gerald Behr, Eralda Mema, Katherine Costa, and Anjali Garg

Link

Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neu, Paul Celano

Link

Quality of Life From Canadian Cancer Trials Group MA.17R: A Randomized Trial of Extending Adjuvant Letrozole to 10 Years, Julie Lemieux, MIchael D. Brundage, Wendy R. Parulekar, Paul E. Goss, James N. Ingle, Kathleen I. Pritchard, Paul Celano, Hyman Muss, Julie Gralow, Kathrin Stasser-Weippl, Kate Whelan, Dongsheng Tu, and Timothy J. Whelan

Link

Optimizing Anticancer Therapy in Metastatic Non-Castrate Prostate Cancer: American Society of Clinical Oncology Clinical Practice Guideline, MIchael J. Morris, R Bryan Rumble, Ethan Basch, Sebastian J. Hotte, Andrew Loblaw, Dana Rathkopf, Paul Celano, Rick Bangs, and Matthew I. Milowsky

Submissions from 2017

Link

The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging, Mahul B. Amin, Frederick L. Greene, Stephen B. Edge, Carolyn C. Compton, Jeefrey E. Gershenwald, Robert K. Brookland, Laura Meyer, Donna M. Gress, David R. Byrd, and David P. Winchester

Link

Immune Correlates of GM-CSF and Melanoma Peptide Vaccination in a Randomized Trial for the Adjuvant Therapy of Resected High-Risk Melanoma (E4697), Lisa H. Butterfield, Fengmin Zhao, Sandra Lee, Ahmad A. Tarhini, Kim A. Margolin, Richard L. White, Michael B. Atkins, Gary I. Cohen, Theresa L. Whiteside, John M. Kirkwood, and David H. Lawson

Link

Phase III Randomized Study of 4 Weeks of High-Dose Interferon-α-2b in Stage T2bNO, T3a-bNO, T4a-bNO, and T1-4N1a-2a (microscopic) Melanoma: A Trial of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group (E1697), Gary I. Cohen

Link

Society of Interventional Radiology: Occupational Back and Neck Pain and the Interventional Radiologist, Robert G. Dixon, Vishal Khiatani, John D. Statler, Eric M. Walser, Mehran Midia, Donald L. Miller, Gabriel Bartal, Jeremy D. Collins, Kathleen A. Gross, Michael S. Stecker, Boris Nikolic, and Society of Interventional Radiology Safety and Health Committee

Link

A phase 2 trial of dasatinib in patients with locally advanced or stage IV mucosal, acral, or vulvovaginal melanoma: A trial of the ECOG-ACRIN Cancer Research Group (E2607), Kevin Kalinsky, Sandra Lee, Krista M. Rubin, Donald P. Lawrence, Anthony J. Iafrarte, Darell R. Borger, Kim A. Margolin, Mario M. Leitao Jr, Ahmad A. Tarhini, Henry B. Koon, Andrew L. Pecora, Anthony J. Jaslowski, Gary I. Cohen, Timothy M. Kuzel, Chrsitopher D. Lao, and John M. Kirkwood

Link

Solitary fibrous tumor of the vulva resulting in spinal metastasis: A case report, Diana C. Pearre, Jerome J. Federspiel, and Francis C. Grumbine

Submissions from 2016

Link

Ebola and Other Highly Contagious Diseases: Strategies by the Society of Interventional Radiology for Interventional Radiology, Nadine Abi-Jaoudeh, Eric M. Walser, Gabriel Bartal, Alan M. Cohen, Jeremy D. Collins, Kathleen A. Gross, Michael S. Stecker, and Boris Nikolic

Submissions from 2015

Link

Radiation Oncology Resident In-Training Examination, Sandra S. Hatch, Neha Vapiwala, Seth A. Rosenthal, John P. Plastaras, Albert L. Blumberg, William Small, Matthew J. Wenger, and Marie E. Taylor

Link

Can older women with early breast cancer avoid radiation?, Kevin S. Hughes and Lauren A. Schnaper